Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Ardent Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on March 9, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Ardent Health securities between July 18, 2024, and November 12, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The deadline to move the Court to serve as lead plaintiff is March 9, 2026, with the lead plaintiff acting on behalf of other class members [3]. Group 2: Case Background - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming an active monitoring process that was not actually employed [5]. - Defendants reportedly downplayed increased claim denials by third-party payors and did not write off uncollectible accounts, which allowed them to report inflated accounts receivable [5]. - The firm also failed to maintain sufficient professional malpractice liability insurance, which was inadequate to cover claims arising from operations, particularly in the New Mexico market [5].
ARDT DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT